P. Waldron

发表

Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance gene 1.

M. Cairo, R. Wells, L. Odom, 1994, Medical and pediatric oncology.

The use of activated factor VII for ventricular septal defect closure in a pediatric patient with hemophilia A and a high titer of inhibitor.

P. Waldron, Duncan G. de Souza, B. Peeler, 2009, Journal of cardiothoracic and vascular anesthesia.

Successful management of stage 4S neuroblastoma and severe hepatomegaly using absorbable mesh in an infant.

P. Waldron, B. Rodgers, E. McGahren, 1998, Journal of pediatric surgery.

Wound healing complications with lenvatinib identified in a pharmacovigilance database

P. Waldron, Connie Cheng, Afrouz Nayernama, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Conservative management of an acute spontaneous holocord epidural hemorrhage in a hemophiliac infant.

J. Jane, P. Waldron, E. Kiehna, 2010, Journal of neurosurgery. Pediatrics.

Chlamydia pneumoniae and Acute Chest Syndrome in Patients With Sickle Cell Disease

L. Benjamin, C. Pegelow, E. Vichinsky, 2003, Journal of pediatric hematology/oncology.

Mycoplasma disease and acute chest syndrome in sickle cell disease.

P. Swerdlow, E. Vichinsky, E. Lennette, 2003, Pediatrics.

Pediatric Angiosarcoma of the Heart: A Unique Presentation and Metastatic Pattern

M. Stoler, P. Waldron, R. Legallo, 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

The Hepatopulmonary Syndrome Masquerading as Pulmonary Langerhans-Cell Histiocytosis

M. Gaffey, T. Pruett, P. Waldron, 1994, Annals of Internal Medicine.

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin

P. Waldron, H. Wong, E. Eworuke, 2021, Drug Safety.

Unusual Neisseria species as a cause of infection in patients taking eculizumab.

P. Waldron, L. McNamara, Page E. Crew, 2019, The Journal of infection.

Malignant rhabdoid tumor of the kidney: Involvement of chromosome 22

M. Lovell, V. Shashi, P. Waldron, 1994, Genes, chromosomes & cancer.

Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature

P. Waldron, B. Kanapuru, Afrouz Nayernama, 2020, American journal of hematology.

Reports to FDA of fatal anaphylaxis associated with intravenous iron products

S. Bird, P. Waldron, Cunlin Wang, 2016, American journal of hematology.

Effects of deferasirox dose and decreasing serum ferritin concentrations on kidney function in paediatric patients: an analysis of clinical laboratory data from pooled clinical studies.

P. Waldron, Mona Khurana, J. Major, 2019, The Lancet. Child & adolescent health.

Neonatal Hematology: Hemolytic disease of the fetus and newborn

P. Waldron, W. Cashore, 2005 .

Interferon treatment of chronic active hepatitis C during therapy of acute lymphoblastic leukemia

P. Waldron, 1999, American journal of hematology.

Hepatoblastoma and heart transplantation in a patient with cardio‐facio‐cutaneous syndrome

K. Gripp, P. Waldron, D. Chute, 2007, American journal of medical genetics. Part A.

Iron deficiency in children with lead exposure.

P. Waldron, 2000, The Journal of pediatrics.

Clonal remission in childhood acute myeloid leukemia is an infrequent event.

W. Woods, J. Singer, B. Lange, 1993, Leukemia.

Successful treatment of a patient with stage IV rhabdoid tumor of the kidney: case report and review.

P. Waldron, R. Womer, B. Rodgers, 1999, Journal of pediatric hematology/oncology.

Disseminated gonococcal infections in patients receiving eculizumab: a case series.

R. Kirkcaldy, K. Bernstein, P. Waldron, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group.

C. Pegelow, E. Vichinsky, P. Waldron, 1999, Journal of pediatric hematology/oncology.

BCR‐ABL1 tyrosine kinase inhibitor‐associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

P. Waldron, R. A. de Claro, Afrouz Nayernama, 2020, American journal of hematology.

FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma

Sarah E. Dorff, K. Goldberg, R. Pazdur, 2020, Clinical Cancer Research.

Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease: Antibiotic prophylaxis and eculizumab.

P. Waldron, L. McNamara, Page E. Crew, 2019, The Journal of infection.

ABO Hemolytic Disease of the Newborn: A Unique Constellation of Findings in Siblings and Review of Protective Mechanisms in the Fetal-Maternal System

P. Waldron, P. D. de Alarcon, 1999, American journal of perinatology.

Cases of Benzocaine-Associated Methemoglobinemia Identified in the FDA Adverse Event Reporting System and the Literature

P. Waldron, Page E. Crew, Allison Lardieri, 2019, The Annals of pharmacotherapy.

Conservative management of an acute spontaneous holocord epidural hemorrhage in a hemophiliac infant.

J. Jane, P. Waldron, E. Kiehna, 2010, Journal of neurosurgery. Pediatrics.